.

ISSN 2063-5346
For urgent queries please contact : +918130348310

PERINATAL AND HEMODYNAMIC EVALUATION OF SILDENAFIL CITRATE FOR PREECLAMPSIA TREATMENT

Main Article Content

Ashraf Samir Faheem1 , Mohammed Hassan Mostafa1 , Eman Zein ElAbdeen Farid1 , Naglaa Mahmoud Mostafa1*
» doi: 10.31838/ecb/2023.12.9.181

Abstract

Background: It is estimated that anywhere from 2 to 8 percent of all pregnancies are affected by the condition known as preeclampsia. This disease is one of the main causes to the morbidity and death of both females and newborns. Erectile dysfunction and pulmonary hypertension are both treatable conditions that can be helped by taking sildenafil citrate.When treating preeclampsia in the setting of severe prematurity, adopting a more positive outlook on the patient's prognosis may result in better perinatal results

Article Details